Document Status

This document has been corrected

Intravenous and subcutaneous formulations of trastuzumab, and trastuzumab biosimilars: implications for clinical practice

10.1038/s41416-020-01255-z

Published Online: 2021-02-16

Journal: British Journal of Cancer•Publisher: Springer Science and Business Media LLC

Authors: Adolfo Fuentes-Alburo•Cornelius F. Waller•Julia Möbius

This document has been corrected

Intravenous and subcutaneous formulations of trastuzumab, and trastuzumab biosimilars: implications for clinical practice

10.1038/s41416-020-01255-z

Published Online: 2021-02-16

Journal: British Journal of Cancer

Authors: Adolfo Fuentes-Alburo•Cornelius F. Waller•Julia Möbius

NOW

2024-07-03•Correction

Correction to: Intravenous and subcutaneous formulations of trastuzumab, and trastuzumab biosimilars: implications for clinical practice

10.1038/s41416-024-02769-6

* information provided by CrossRef

2024-07-03•Correction

10.1038/s41416-024-02769-6

* information provided by CrossRef

2021-02-16•Published